The phase 3 program missed both primary and key secondary endpoints, with no statistically significant effects on relevant measures observed for patients receiving investigational treatment ...

Phase I—Determining the Current Status of the Brand The purpose of this phase is to understand the company and brand, including exploring key issues, opportunities, and challenges. The reason is to ...

according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center. "KATHERINE is a landmark clinical ...

BBO-8520, an investigational oral agent, has been granted fast track designation from the FDA in previously treated KRAS G12C–mutated metastatic non–small cell lung cancer. The FDA has granted ...

Reducing our carbon footprint requires full commitment to the electrification of industry. This means moving away from technologies powered by fossil fuels to those running on clean energy sources ...